Haemophilia: open trials in Israel

7 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT07416604
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
The Chaim Sheba Medical Center - PPDS, Ramat Gan
Registry updated 2026-11-03
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Trial Treatment · Phase 3 · Pfizer
Sheba medical center, Ramat Gan
Registry updated 2026-10-26
NCT07080905
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Trial Treatment · Phase 3 · CSL Behring
Chaim Sheba Medical Center, Ramat Gan
Registry updated 2026-10-20
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Trial Treatment · Phase 3 · Pfizer
Sheba medical center, Ramat Gan
Registry updated 2026-10-14
NCT06003387
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Trial Treatment · Phase 3 · CSL Behring
Sheba medical center, Tel HaShomer
Registry updated 2026-08-27
NCT05768386
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Research · Phase 4 · BioMarin Pharmaceutical
Chaim Sheba Medical Center, National Institute of Hemophilia and Coagulation, Ramat Gan
Registry updated 2026-01-12
NCT02979119
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Research · PedNet Haemophilia Research Foundation
The National Hemophilia Center Sheba Medical Center, Tel Hashomer, Ramat Gan
Registry updated 2025-09-16

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Haemophilia: open trials in Israel

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

The European Paediatric Network for Haemophilia Management ( PedNet Registry)